A Scoping Review of Transdermal Buprenorphine Use for Non-surgical Pain in the Pediatric Population.

Abstract

 A preliminary evaluation to review the scope and quality of evidence surrounding transdermal buprenorphine use in the pediatric setting for non-surgical pain was conducted. Our review revealed limited data available on the use of transdermal buprenorphine in pediatric patients. Most studies surrounding this subject involve accidental ingestion of buprenorphine and its use in the treatment of neonatal abstinence syndrome. While indicated for use only in adult populations, small studies have shown encouraging results in reducing pain in children with few, if any, adverse effects. This is reassuring from a clinical perspective, as we hope to highlight the available evidence and invite researchers to expand future studies. Through this review, we have identified significant gaps in the literature surrounding the safety and use of buprenorphine in the pediatric population. To our knowledge, there are no major studies investigating this subject, and it is our hope that future studies will explore the use of transdermal buprenorphine as an alternative pain management technique in pediatrics. The intent of our scoping review is to highlight the lack of research in this area; therefore, future studies may be conducted to support its use in North America.

• Authors: Thomas S Haupt, Michael Smyth, Marie-Claude Gregoire
• Journal: Cureus (Cureus) Vol. 11 Issue 10 Pg. e5954 (Oct 21 2019) ISSN: 2168-8184 [Print] United States
• PMID: 31803545 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2019, Haupt et al.